Multifunctional cationic polymer decorated and drug intercalated layered silicate (NLS) for early gastric cancer prevention

Biomaterials

Volumn 35, Issue 10, 2014, Pages 3298-3308

  Jin, Xue ^a,b   Hu, Xiurong ^a   Wang, Qiwen ^a   Wang, Kai ^a   Yao, Qi ^a   Tang, Guping ^a,b   Chu, Paul K ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Attapulgite; Cationic polymer; Drug intercalate; Gastric cancer; Montmorillonite

Indexed keywords

ATTAPULGITES; CATIONIC POLYMERS; DRUG INTERCALATE; EXPERIMENTAL CONDITIONS; GASTRIC CANCERS; HISTOCHEMICAL ANALYSIS; MONTMORILLONITE (MMT); MULTIFUNCTIONAL COMPOUNDS;

CELL CULTURE; CLAY MINERALS; GENES; POLYMERS; PROTEINS; SILICATES;

DISEASES;

ATTAPULGITE; FLICE INHIBITORY PROTEIN; FLUOROURACIL; MONTMORILLONITE; POLYETHYLENEIMINE; SILICATE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BACTERIAL VIABILITY; BACTERIUM ADHERENCE; CANCER PREVENTION; CELL VIABILITY; CHEMICAL BOND; CONTROLLED STUDY; DOWN REGULATION; DRUG RELEASE; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HELICOBACTER PYLORI; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH JUICE; SURFACE PROPERTY; UPREGULATION; WESTERN BLOTTING; ZETA POTENTIAL;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

ATTAPULGITE; CATIONIC POLYMER; DRUG INTERCALATE; GASTRIC CANCER; MONTMORILLONITE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BACTERIAL ADHESION; CATIONS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; FEMALE; FLUOROURACIL; HELICOBACTER PYLORI; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; POLYMERS; SILICATES; STOMACH NEOPLASMS;

EID: 84893686164     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.040     Document Type: Article

References (32)

1. Yao H.B., Mao L.B., Yan Y.X., Cong H.P., Lei X., Yu S.N. Gold nanoparticle functionalized artificial nacre: facile in situ growth of nano-particles on montmorillonite nanosheets, self assemble, and their multiple properties. ACS Nano 2012, 6:8250-8260.
2. Tang F.Q., Li L.L., Chen D. Mesoporous silica nanoparticles:synthesis biocompatibility and drug delivery. Adv Mater 2012, 24:1504-1534.
3. Bitinis N., Hernanden M., Verdejo R., Kenny J.M., Lopez-Manchado M.A. Recent advances in clay/polymer nanocomposites. Adv Mater 2011, 23:5229-5236.
4. Ruiz-Hitzky E., Aranda P., Darder M., Ogawa M. Hybrid and biohybrid silicate based materials: molecular vs block assembling bottom up processes. Chem Soc Rev 2011, 40:801-828.
5. Yao X.Y., Tian X.Y., Zhang X., Zheng K., Zheng J., Zhang H.B., et al. Poly(ethylene terephthalate)attapulgite nanocomposites:preparation, structure, and properties. J Appl Polym Sci 2008, 110:140-146.
6. Dong Y.C., Feng S.S. Poly(D,L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drug. Biomaterials 2005, 26:6068-6076.
7. An L., Pan Y.Z., Shen X.W., Lu H.B., Yang Y.L. Rod-like attapulgite/polyimide nanocomposites with simultaneously improved strength, toughness, thermal stability and related mechanisms. J Mater Chem 2008, 18:4928-4941.
8. Sun B.F., Ranganathan B., Feng S.S. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Transuzumab for targeted chemotherapy of breast cancer. Biomaterials 2008, 29:475-486.
9. Wang X.Y., Du Y.M., Yang J.H., Tang Y.F., Luo J.W. Preparation, characterization, and antimicrobial activity of quaternized chitosan/organic montmorillonite nanocomposites. J Biomed Mater Res Part A 2008, 84A:384-390.
10. Cai D.Q., Zhang H., Tang Y., Chu P.K., Yu Z.L., Wu Z.Y. Nano-networks have better adsorption capability than nano-rods. Nano Commun Netw 2010, 257-263.
11. Vaiana C.A., Leonard M.K., Drummy L.F., Singh K.M., Bubulya A., Vaia R.A., et al. Epidermal growth factor: layered silicate nanocomposites for tissue regeneration. Biomacromolecules 2011, 12:3139-3146.
12. Feng S.S., Mei L., Anitha P., Gan C.W., Zhou W.Y. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials 2009, 30:3297-3306.
13. Ruiz-Hitzky E., Aranda P., Darder M., Rytwo G. Hybrid materials based on clays for environmental and biomedical applications. J Mater Chem 2010, 20:9306-9321.
14. Takahashi T., Suzuki H., Imai T., Shibata S., Tabuchi Y., Tsuchimoto K., et al. Musashi-1 post-transcriptionally enhances phosphotryosine-binding domain containing m-numb protein expression in regeneration gastric mucosa. PLOS One 2013, 18:1-13.
15. Polk D.B., Peek R.M. Helicobacter pylori: gastric cancer and beyond. Cancer 2010, 10:403-414.
16. Ning J.W., Lin G.B., Ji F., Xu J., Sharify N. Preventive effects of geranylgeranylacetone on rat ethanol induced gastritis. World J Gastroenterol 2012, 18:2262-2269.
17. Wei-Chen Tai., Chien-Hua Chiu., Chih-Ming Liang., Chang K.C., Kuo C.M., Chiu Y.C., et al. Ten-day versus 14-day levofloxacin-containing triple therapy for second-line anti-Helicobacter pylori eradication in Taiwan 2013, 6. Gastroenterol Res Pract, Article ID 932478, http://dx.doi.org/10.1155/2013/932478.
18. Xu C.D., Chen S.N., Jiang S.H., Xu J.Y. Seroepidemiology of Helicobacter pylori infection among asymptomatic Chinese children. World J Gastroenterol 2000, 6(5):759-761.
19. Chen C., Chosh S., Grove A. Substrate specificity of Helicobacter pylori istone-like HU protein is determined by insufficient stabilization of DNA flexure points 2004, vol. 383:343-351.
20. Fan H., Hu Q.D., Xu F.J., Liang W.Q., Tang G.P., Yang W.T. In vivo treatment of tumors using host-guest conjugated nanoparticles functionalized with doxorubicin and therapeutic gene pTRAIL. Biomaterials 2012, 33:1428-1436.
21. Hu Q.D., Fan H., Ping Y., Liang W.Q., Tang G.P., Li J. Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug. Chem Commun 2011, 47:5572-5574.
22. Moom J.Y., Cho M., Ahn K.S., Cho S.K. Nobiletin induces apoptosis and potentiates the effects of the anticancer drug 5-fluorouracil in p53-mutated SNU-16 human gastric cancer cells. Nutr Cancer 2013, 65(2):286-295.
23. Mizutani Y., Nakanishi H., Yoshida O., Fukushima M., Bonavida B., Miki T. Potentiation of the sensitivity of renal cell carcinoma cell to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil. Eur J Cancer 2002, 38:167-176.
24. Yamamoto T., Nagano H., Sakon M., Wada H., Eguchi H., Kondo M., et al. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects interferon-α/5-fluorouracil against hepatocellular carcinoma. Clin Cancer Res 2004, 10:7884-7895.
25. Lee K.C., Hamstra D.A., Bhojani M.S., Khan A.P., Ross B.D., Rehemtulla A. Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/apo2l for cancer therapy. Clin Cancer Res 2007, 13(6):1839-1846.
26. Jin X., Wang Q.W., Hu T.N., Xu S., Hu Q.D., Zhou J., et al. Modified montmorillonite as multifunction gene and drug delivery system. J Zhejiang Univ Med Sci 2012, 41:631-638.
27. Galligan L., Longley D.B., McEwan M., Wilson T.R., McLaughlin K., Johnson P.G. Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP. Mol Cancer Ther 2005, 4:2026-2036.
28. Stagni V., Mingardi M., Santini S., Giaccari D., Barila D. ATM kinase activity modulates Cflip protein levels: potential interplay between DNA damage signalling and TRAIL induced apoptosis. Carcinogenesis 2010, 31:1956-1963.
29. Fullenkamp D.E., Rivera J.G., Gong Y.K., Aaron Lau K.H., He L.H., Varshney R., et al. Mussel-inspired silver-releasing antibacterial hydrogels. Biomaterials 2012, 33:3783-3791.
30. Zheng F., Wang S., Wen S., Shen M., Zhu M., Shi X. Characterization and antibacterial activity of amoxicillin-loaded electrospun. Biomaterials 2013, 34:1402-1412.
31. Alt V., Bechert T., Steinrucke P., Waqener M., Seidel P., Dinqeldein E. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004, 25:4383-4391.
32. Liu W.L., Chen S.J., Chen Y., Sun L.M., Zhang W., Zeng Y.M., et al. Protective effects of heat shock protein70 induced by geranylgeranylacetone in atrophic gastritis in rats. Acta Pharmacol Sin 2007, 28(7):1001-1006.